Manager firm
Marylebone Partners LLP
Structure
investment_trust
AIC sector
Flexible Investment
Domicile
United Kingdom
Base currency
GBP
Latest factsheet
2026-03-31
Snapshot date
2025-08-31
Manager firm
Marylebone Partners LLP
Structure
investment_trust
AIC sector
Flexible Investment
Domicile
United Kingdom
Base currency
GBP
Latest factsheet
2026-03-31
Snapshot date
2025-08-31
Share price
293.50p
NAV / share
329.01p2026-05-15
Premium / discount
-10.79%
Fund size
£148m
OCF
—
Performance fee
—
Gearing
—
Dividend yield
0.75%
| Period | Return | Benchmark | Vs |
|---|---|---|---|
| ytd | -5.4% | — | — |
| 1y | 4.3% | — | — |
| 1y | 15.3% | — | — |
| Period | Return | Benchmark | Vs |
|---|---|---|---|
| 3y | 11.4% | — | — |
| 3y | 13.9% | — | — |
| 5y | 6.0% | — | — |
| 5y | 7.9% | — | — |
| # | Holding | Sector | Country | Weight |
|---|---|---|---|---|
| 1 | Project Uranium | Thematic | — | 3.2% |
| 2 | Project Vista | Co-invest | — | 1.6% |
| 3 | Project Ox | Co-invest | — | 1.5% |
| 4 | Project Senior | Co-invest | — | 1.5% |
| 5 | Project Sherpa | Co-invest | — | 1.3% |
| 6 | Paradigm BioCapital | Biotech | — | 5.9% |
| 7 | Perseverance DXF Value | Regional (China) | — | 5.6% |
| 8 | Silver Point | Credit | — | 5.2% |
| 9 | Contrarian EM | EM Credit | — | 5.1% |
| 10 | Helikon L/S Equity | Regional (Europe) | — | 4.9% |
| Flexible | — |
| Cayman Islands | 50.3% | |
| USA | 16.4% | |
| UK | 9.3% | |
| Cash near Cash | 6.2% | |
| Ireland | 4.4% | |
| Luxembourg | 4.0% | |
| Fixed Interest | 3.5% | |
| Japan | 2.8% | |
| Cyprus | 2.7% | |
| Germany | 2.3% |
| Portfolio yield | 0.74% |
| Unlisted holdings | 0.40% |
| Cash & equivalents | 6.20% |
| Total assets | £152.4m |
| Revenue reserves | £0 |
| Net gearing | 0.00% |
| Gross gearing | 0.00% |
| Net cash | £0 |
| Gearing range (from) | — |
| Gearing range (to) | — |
| Shares in issue | 52,998,795 |
| Shares issued | 0 |
| Shares purchased | 0 |
| Treasury shares | 0 |
Manager firm
Marylebone Partners LLP
Structure
investment_trust
AIC sector
Flexible Investment
Domicile
United Kingdom
Base currency
GBP
Latest factsheet
2026-03-31
Snapshot date
2025-08-31
Share price
293.50p
NAV / share
329.01p2026-05-15
Premium / discount
-10.79%
Fund size
£148m
OCF
—
Performance fee
—
Gearing
—
Dividend yield
0.75%
| Period | Return | Benchmark | Vs |
|---|---|---|---|
| ytd | -5.4% | — | — |
| 1y | 4.3% | — | — |
| 1y | 15.3% | — | — |
| Period | Return | Benchmark | Vs |
|---|---|---|---|
| 3y | 11.4% | — | — |
| 3y | 13.9% | — | — |
| 5y | 6.0% | — | — |
| 5y | 7.9% | — | — |
| # | Holding | Sector | Country | Weight |
|---|---|---|---|---|
| 1 | Project Uranium | Thematic | — | 3.2% |
| 2 | Project Vista | Co-invest | — | 1.6% |
| 3 | Project Ox | Co-invest | — | 1.5% |
| 4 | Project Senior | Co-invest | — | 1.5% |
| 5 | Project Sherpa | Co-invest | — | 1.3% |
| 6 | Paradigm BioCapital | Biotech | — | 5.9% |
| 7 | Perseverance DXF Value | Regional (China) | — | 5.6% |
| 8 | Silver Point | Credit | — | 5.2% |
| 9 | Contrarian EM | EM Credit | — | 5.1% |
| 10 | Helikon L/S Equity | Regional (Europe) | — | 4.9% |
| Flexible | — |
| Cayman Islands | 50.3% | |
| USA | 16.4% | |
| UK | 9.3% | |
| Cash near Cash | 6.2% | |
| Ireland | 4.4% | |
| Luxembourg | 4.0% | |
| Fixed Interest | 3.5% | |
| Japan | 2.8% | |
| Cyprus | 2.7% | |
| Germany | 2.3% |
| Portfolio yield | 0.74% |
| Unlisted holdings | 0.40% |
| Cash & equivalents | 6.20% |
| Total assets | £152.4m |
| Revenue reserves | £0 |
| Net gearing | 0.00% |
| Gross gearing | 0.00% |
| Net cash | £0 |
| Gearing range (from) | — |
| Gearing range (to) | — |
| Shares in issue | 52,998,795 |
| Shares issued | 0 |
| Shares purchased | 0 |
| Treasury shares | 0 |